YESWEHACK
10.3.2022 09:02:05 CET | Business Wire | Press release
Telenor Sweden has partnered with YesWeHack , Europe’s leading Bug Bounty platform, to identify potential vulnerabilities on its critical telecom infrastructure and protect customer information.
Telenor is a leading telecommunications company across the Nordics and Asia with more than 188 million customers worldwide. It has mobile operations in the Nordics, including Norway, Sweden, Denmark, Finland and in Asia, including Pakistan, Bangladesh, Thailand, Malaysia, and Myanmar. Connecting customers to what matters most has been the core of its business for more than 160 years.
Telenor’s wholly owned subsidiary, Telenor Sweden, is one of the largest mobile operator in the country and provider of fixed broadband services to the consumer and business markets in Sweden.
Telecom companies maintain and operate critical communications infrastructure. This is used to transmit large amounts of sensitive consumer and business data, due to which cyberattacks against the industry are soaring. Meanwhile, the rapid advancements of new technologies such as the Internet of Things (IoT) and 5G dramatically increase the potential attack surface and threat landscape for a telco.
To protect customer data and the security of its critical infrastructure, Telenor is investing in security capabilities across its organisation as well as with its suppliers and third-party providers. It ensures the same level of control over data and infrastructure, independent of operating – or business model.
One such initiative is crowdsourcing security through a bug bounty program with YesWeHack to identify security gaps and ensure adequate data protection. Crowdsourced security will help Telenor Sweden access a diverse range of security researchers, also called hunters, with unique specialisations and in-depth industry knowledge.
“The partnership with YesWeHack is one of the ways we work with security and maybe one of the most important ones in our proactive work to stop cybercriminals. The return on investment is huge since we get access to thousands of security researchers while only paying a fraction of the cost it would take to recruit them all individually,” said Ulf Andersson, Head of Information Security at Telenor Sweden. “We are now planning to level up both the private and public program to make it even more attractive and generate more reports,” he added.
Telenor Sweden had started with a private bug bounty program where YesWeHack invited selected researchers to hack it’s infrastructure. This was followed by a public bug bounty program where the telco is now being scrutinised by the entire YesWeHack community, representing more than 35,000 global cybersecurity researchers.
“Through the YesWeHack bug bounty program, we are connected to one of the finest global networks of hackers to help us find security gaps in our infrastructure. It's all about finding vulnerabilities before anyone else. By being proactive and allowing the hacking of our infrastructure, we can find weaknesses before the criminals do and fix them,” said Marcus Lundblad, Security Engineer at Telenor Sweden.
By reducing security gaps and ensuring adequate data protection, Telenor Sweden gives its customers the comfort to share information and allow them to reap the benefits of the data-driven economy.
“Protecting people in their digital life with security at the foundation is the core value of Telenor,” said Guillaume Vassault-Houlière, CEO and Co-Founder of YesWeHack. “Telenor Sweden has achieved the position of a trusted and secure provider in all markets because of its focus on customer data protection and by defending its critical infrastructure by adopting game-changing solutions such as bug bounty,” he added.
Cybersecurity experts from Telenor Sweden will share best practices on guarding against cyber threats in a webinar on March 17th 2022. They will also share why the organisation has put bug bounty at the core of its security posture and will detail the clear benefits of a platform-driven, results-oriented and crowdsourced approach to security audits. For more information and registration visit our blog .
ABOUT YESWEHACK
Founded in 2015, YesWeHack is the #1 European Bug Bounty & VDP Platform. YesWeHack offers companies an innovative approach to cybersecurity with Bug Bounty (pay-per-vulnerability discovered), connecting more than 35,000 cybersecurity experts (ethical hackers) across 170 countries with organisations to secure their exposed scopes and reporting vulnerabilities in their websites, mobile apps, infrastructure and connected devices. YesWeHack runs private and public programs for hundreds of organisations worldwide in compliance with the strictest European regulations.
In addition to the Bug Bounty platform, YesWeHack also offers support in creating a Vulnerability Disclosure Policy (VDP), a learning platform for ethical hackers called Dojo and a training platform for educational institutions, YesWeHackEDU. For more information: www.yeswehack.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220310005007/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
